FH Europe Foundation
Magdalena Daccord is currently the Chief Executive Officer at FH Europe Foundation, leading a network of 25 patient organizations to ensure early detection and treatment of Familial Hypercholesterolemia. Magdalena has previously held various leadership positions in organizations like Women's Brain Project, DIA, and Alexion Pharmaceuticals, gaining extensive experience in operations, marketing, events management, and project coordination. Magdalena holds a Master's degree in Sports and Leisure Management and has pursued further education in digital marketing.
This person is not in any teams
This person is not in any offices
FH Europe Foundation
The European FH Patient Network in an umbrella organization of international patient networks, actively working together to secure early identification and diagnosis of Famillial Hypercholesterolemia (FH) and other inherited lipid conditions, incl rare forms, to prevent early cardiovascular disease (CVD). Charity Registration number: 1170731 Familial Hypercholesterolaemia (FH) is an inherited condition that leads to levels of cholesterol that are higher than that of the general population, sometimes double or even three or four times. FH affects around 1 in 250 people – but the prevalence may vary across Europe. FH is a genetic condition caused by a ‘spelling mistake’ in our DNA – the genetic material with all the instructions needed to ‘build’ humans.